Gene Panel Market Size, Share & Trends Analysis Report By Product & Services (Test Kits, Testing Services), By Technique, By Design, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Gene Panel Market Growth & Trends

The global gene panel market size is expected to reach USD 2.72 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 15.52% from 2022 to 2030. A rise in the number of congenital disorders, coupled with an unprecedented increase in the number of cancer cases across the globe, is anticipated to drive the market. Early diagnosis of chromosomal disorders enables timely prognosis and therapeutic steps to be taken so as to retard the symptoms and improve the quality of life.

Furthermore, an increase in hereditary level understanding and a rise in the need for genetic screening, personalized medicine, risk analysis, and prognostics are anticipated to drive the market. A specific group of genes needs to be sequenced and analyzed to understand the genetic predisposition of a disease condition. The panels help in sequencing specific genes that are known to be causative of the disease condition. There are many predesigned panels for particular disease conditions along with options for customization. There also have been consistent research efforts to devise novel gene panels to efficiently diagnose a wide spectrum of genetic disorders.

For instance, INVIEW Liquid Biopsy Onco-profiling is an all-inclusive comprehensive cancer gene panel for examination using liquid biopsy samples like blood. Customizable gene panels are also available that can be customized based on specific requirements. For instance, QIAseq multimodal custom panel is a customizable gene panel that is able to profile variant DNA, RNA fusion, and gene expression patterns from a single sample input.

The COVID-19 pandemic has significantly disrupted the delivery of effective healthcare services, including genetic counseling and genetic testing services. There are efforts across the U.S. to ensure re-igniting genetic testing, at least for pre-implantation screening. However, the ramping up of genetic screening for cancer has also become a part of the mission of cancer societies across the globe.

Moreover, many researchers and clinicians believe that there is a strong necessity for the enforcement of genetic screening procedures to bring down the mortality rate due to genetic disorders, and therefore there will be a rise in the demand for gene panels during the forecast period. For instance, all those born in the U.S. are compulsorily screened using a blood sample for certain genetic, endocrine, metabolic, hearing, and critical congenital heart disorders.

Gene Panel Market Report Highlights

  • By products & services, the test kits segment held the largest share in 2021 due to the utilitarian benefits that a test kit could offer to clinicians, researchers, and the normal population. Ready-to-use kits and self-administrable diagnostic kits are increasingly trending these days
  • By technique, the hybridization-based approach is in the growth phase due to the reliability of outcomes, though the technique is expensive and time-consuming. Gene panels are usually designed for the analysis of several genes and the hybridization technique is conducive to this concept of gene panel testing
  • By design, predesigned gene panels dominated the market in 2021. This is because predesigned gene panels are preferred over customizable gene panels for diagnostic utility because predesigned panels are backed by research for outcome reliability
  • By application, the cancer risk assessment segment is expected to grow lucratively during the forecast period due to a rise in the number of cancer cases and increased recommendations for cancer screening across different countries
  • North America dominated the global market in 2021 owing to the increasing demand for genetic screening and early cancer screening, the presence of key players, the rising prevalence of cancer, and rising recommendations for newborn screening
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.2.1 Information Procurement
1.2.2 Information Analysis
1.2.3 Market Formulation
1.2.4 Validation & Publishing
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Market Summary
Chapter 3 Gene Panel Market Variables, Trends, & Scope
3.1 Gene Panel Market Variables, Trends, and Scope
3.2 Market Driver Analysis
3.2.1 Growing Incidence of Genetic Disorders
3.2.2 Rising Need for Personalized Medicine
3.2.3 High Specificity and Reliability
3.2.4 Market Restraint Analysis
3.2.5 Exorbitant Cost Factor
3.2.6 Limited Understanding
3.2.7 Market Opportunity Analysis
3.2.8 Market Threat Analysis
3.3 Industry Analysis - Porter’s
3.4 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
Chapter 4 Gene Panel Market - Segment Analysis, by Product & Services, 2018 - 2030 (USD Million)
4.1 Gene Panel Market: Product & Services Movement Analysis
4.1.1 Test Kits
4.1.1.1 Global test kits based gene panel market, 2018 - 2030 (USD Million)
4.1.2 Testing Services
4.1.2.1 Global testing services based gene panel Market, 2018 - 2030 (USD Million)
Chapter 5 Gene Panel Market - Segment Analysis, by Technique, 2018 - 2030 (USD Million)
5.1 Gene Panel Market: Technique Movement Analysis
5.1.1 Amplicon Based Approach
5.1.1.1 Global amplicon based approach gene panel market, 2018 - 2030 (USD Million)
5.1.2 Hybridization Based Approach
5.1.2.1 Global hybridization based approach gene panel market, 2018 - 2030 (USD Million)
Chapter 6 Gene Panel Market - Segment Analysis, by Design, 2018 - 2030 (USD Million)
6.1 Predesigned Gene Panel
6.1.1 Global predesigned gene panel market, 2018 - 2030 (USD Million)
6.2 Customized Gene Panel
6.2.1 Global customized gene panel market, 2018 - 2030 (USD Million)
Chapter 7 Gene Panel Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
7.1 Cancer Risk Assessment
7.1.1 Global cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
7.1.2 Syndrome Specific Cancer Risk Assessment
7.1.2.1 Global syndrome specific cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
7.1.3 High Penetrance Cancer Risk Assessment
7.1.3.1 Global high penetrance cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
7.1.4 High & Moderate Penetrance Cancer Risk Assessment
7.1.4.1 Global high & moderate penetrance cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
7.1.5 Comprehensive Cancer Risk Assessment
7.1.5.1 Global comprehensive cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
7.2 Diagnosis of Congenital Diseases
7.2.1 Global diagnosis of congenital diseases based gene panel market, 2018 - 2030 (USD Million)
7.3 Pharmacogenetics
7.3.1 Global pharmacogenetics based gene panel market, 2018 - 2030 (USD Million)
7.4 Other Applications
7.4.1 Global other applications based gene panel market, 2018 - 2030 (USD Million)
Chapter 8 Gene Panel Market - Segment Analysis, by End-Use, 2018 - 2030 (USD Million)
8.1 Research and Academic Institutes
8.1.1 Global research and academic institutes based gene panel market, 2018 - 2030 (USD Million)
8.2 Hospital and Diagnostic Laboratories
8.2.1 Global hospital and diagnostic laboratories market, 2018 - 2030 (USD Million)
8.3 Pharmaceutical and Biotechnology Companies
8.3.1 Global pharmaceutical and biotechnology companies based gene panel market, 2018 - 2030 (USD Million)
Chapter 9 Gene Panel Market -Regional Business Analysis
9.1 Regional Market Snapshot
9.2 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
9.3 North America
9.3.1 North America gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2 U.S.
9.3.2.1 U.S. gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.3 Canada
9.3.3.1 Canada gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.4 Europe
9.4.1 Europe gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.2 U.K.
9.4.2.1 U.K. gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.3 Germany
9.4.3.1 Germany gene panels market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.4 France
9.4.4.1 France gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.5 Italy
9.4.5.1 Italy gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.6 Spain
9.4.6.1 Spain gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.7 Russia
9.4.7.1 Russia gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.2 Japan
9.5.2.1 Japan gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.3 China
9.5.3.1 China gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.4 India
9.5.4.1 India gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.5 South Korea
9.5.5.1 South Korea gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.6 Australia
9.5.6.1 Australia gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.6 Latin America
9.6.1 Latin America gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Brazil gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Mexico gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.4 Argentina
9.6.4.1 Argentina gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.7 Middle East & Africa (MEA)
9.7.1 MEA gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.2 South Africa
9.7.2.1 South Africa gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.3 Saudi Arabia
9.7.3.1 Saudi Arabia gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.4 UAE
9.7.4.1 UAE gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10 Gene Panel Market - Competitive Analysis
10.1 Recent Developments & Impact Interpretation, by Key Market Participants
10.1.1 ANSOFF MATRIX
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.2.3 Key Customers
10.3 Synergy Interpretation: Major Deals & Strategic Alliances
10.3.1 New Product Launch
10.3.2 Acquisition
10.3.3 Expansion
10.3.4 Partnerships
10.3.5 Marketing & Promotions
10.4 Company Profiles
10.4.1 AGILENT TECHNOLOGIES INC.
10.4.1.1 Company overview
10.4.1.2 Financial performance
10.4.1.3 Product benchmarking
10.4.1.4 Strategic initiatives
10.4.2 ILLUMINA INC.
10.4.2.1 Company overview
10.4.2.2 Financial performance
10.4.2.3 Product benchmarking
10.4.2.4 Strategic initiatives
10.4.3 QIAGEN INC.
10.4.3.1 Company overview
10.4.3.2 Financial performance
10.4.3.3 Product benchmarking
10.4.3.4 Strategic initiatives
10.4.4 EUROFINS GENOMICS
10.4.4.1 Company overview
10.4.4.2 Financial performance
10.4.4.3 Product benchmarking
10.4.4.4 Strategic initiatives
10.4.5 INIVATA
10.4.5.1 Company overview
10.4.5.2 Financial performance
10.4.5.3 Product benchmarking
10.4.5.4 Strategic initiatives
10.4.6 SINGLERA GENOMICS
10.4.6.1 Company overview
10.4.6.2 Financial performance
10.4.6.3 Product benchmarking
10.4.6.4 Strategic initiatives
10.4.7 GENECAST
10.4.7.1 Company overview
10.4.7.2 Financial performance
10.4.7.3 Product benchmarking
10.4.7.4 Strategic initiatives
10.4.8 FOUNDATION MEDICINE INC.
10.4.8.1 Company overview
10.4.8.2 Financial performance
10.4.8.3 Product benchmarking
10.4.8.4 Strategic initiatives
10.4.9 23ANDME, INC.
10.4.9.1 Company overview
10.4.9.2 Financial performance
10.4.9.3 Product benchmarking
10.4.9.4 Strategic initiatives
10.4.10 FREENOME
10.4.10.1 Company overview
10.4.10.2 Financial performance
10.4.10.3 Product benchmarking
10.4.10.4 Strategic initiatives
10.4.11 MYRIAD GENETICS
10.4.11.1 Company overview
10.4.11.2 Financial performance
10.4.11.3 Product benchmarking
10.4.11.4 Strategic initiatives
10.4.12 CEPHEID (DANAHER)
10.4.12.1 Company overview
10.4.12.2 Financial performance
10.4.12.3 Product benchmarking
10.4.12.4 Strategic initiatives
10.4.13 BIORAD LABORATORIES INC.
10.4.13.1 Company overview
10.4.13.2 Financial performance
10.4.13.3 Product benchmarking
10.4.13.4 Strategic initiatives
10.4.14 BGI GENOMICS INC.
10.4.14.1 Company overview
10.4.14.2 Financial performance
10.4.14.3 Product benchmarking
10.4.14.4 Strategic initiatives
10.4.15 INVITAE CORPORATION
10.4.15.1 Company overview
10.4.15.2 Financial performance
10.4.15.3 Product benchmarking
10.4.15.4 Strategic initiatives
10.4.16 CENTOGENE N.V.
10.4.16.1 Company overview
10.4.16.2 Financial performance
10.4.16.3 Product benchmarking
10.4.16.4 Strategic initiatives
10.4.17 GENE DX, LLC (SEMA4)
10.4.17.1 Company overview
10.4.17.2 Financial performance
10.4.17.3 Product benchmarking
10.4.17.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings